FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

N M A Blijlevens

Research Profile

Procedures

Activities & Behaviors

Thermometry

Disorders

Chemicals & Drugs

Anatomy

Living Beings

Young Adult

Co-author Network

Publications

TOP 3
Walter J F M van der Velden; Anton F J de Haan; J Peter Donnelly; Gerwin A Huls; Mihai G Netea; N M A Blijlevens
Role of the mycobiome in human acute graft-versus-host disease.
Willemijn Hobo; Joop H Jansen; Michel Kester; Frank W M B Preijers; NP Schaap; Ton Schattenberg; Bert A van der Reijden; Walter J F M van der Velden; Yannick Wouters; Niken Adisty; N M A Blijlevens; Kelly Broen; Theo de Witte; J H Frederik Falkenburg; Ton Feuth; Hanny Fredrix; Annelies Greupink-Draaisma; Harry Dolstra
Association of disparities in known minor histocompatibility antigens with relapse-free survival and graft-versus-host disease after allogeneic stem cell transplantation.
H M Blommestein; Jan J Cornelissen; P C Huijgens; N M A Blijlevens; S G R Verelst; Carin A Uyl-de Groot
Real-world costs of autologous and allogeneic stem cell transplantations for haematological diseases: a multicentre study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of N M A Blijlevens (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Walter J F M van der Velden; Anton F J de Haan; J Peter Donnelly; Gerwin A Huls; Mihai G Netea; N M A Blijlevens
Role of the mycobiome in human acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(2):329-32.
2013: Willemijn Hobo; Joop H Jansen; Michel Kester; Frank W M B Preijers; NP Schaap; Ton Schattenberg; Bert A van der Reijden; Walter J F M van der Velden; Yannick Wouters; Niken Adisty; N M A Blijlevens; Kelly Broen; Theo de Witte; J H Frederik Falkenburg; Ton Feuth; Hanny Fredrix; Annelies Greupink-Draaisma; Harry Dolstra
Association of disparities in known minor histocompatibility antigens with relapse-free survival and graft-versus-host disease after allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(2):274-82.
2012: H M Blommestein; Jan J Cornelissen; P C Huijgens; N M A Blijlevens; S G R Verelst; Carin A Uyl-de Groot
Real-world costs of autologous and allogeneic stem cell transplantations for haematological diseases: a multicentre study.
Annals of hematology 2012;91(12):1945-52.
2012: W J F M van der Velden; J P Donnelly; N M A Blijlevens
Lymphocyte subsets, granulocyte-colony-stimulating factor responsiveness and post-stem cell transplantation infections: mucositis is the underestimated confounder?
Cytotherapy 2012;14(3):381-3.
2012: Anniek B van der Waart; Astrid G S van Halteren; N M A Blijlevens; Ton Feuth; Marij J L G Leenders; Walter J F M van der Velden; Robbert van der Voort; Harry Dolstra
Decreased levels of circulating IL17-producing CD161+CCR6+ T cells are associated with graft-versus-host disease after allogeneic stem cell transplantation.
PloS one 2012;7(12):e50896.
2011: Walter J F M van der Velden; N M A Blijlevens; J Peter Donnelly
Genetic variants and the risk for invasive mould disease in immunocompromised hematology patients.
Current opinion in infectious diseases 2011;24(6):554-63.
2011: FM Verduyn Lunel; J Peter Donnelly; N M A Blijlevens; Henrich A L van der Lee; Paul E Verweij
Performance of the new Platelia Candida Plus assays for the diagnosis of invasive Candida infection in patients undergoing myeloablative therapy.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2011;49(8):848-55.
2011: Kelly Broen; N M A Blijlevens; Ton Feuth; Annelies Greupink-Draaisma; Julia Metzig; NP Schaap; Walter J F M van der Velden; Anniek B van der Waart; Harry Dolstra
Polymorphisms in CCR6 are associated with chronic graft-versus-host disease and invasive fungal disease in matched-related hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(10):1443-9.
2011: W J F M van der Velden; J P Donnelly; N M A Blijlevens
Differences in T cell depletion and intestinal mucositis explain inconsistent effects of NOD2/CARD15 polymophisms in SCT.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(10):1421-3.
2011: M van Vliet; J P Donnelly; C M J Potting; P D J Sturm; N M A Blijlevens
How prompt is prompt in daily practice? Earlier initiation of empirical antibacterial therapy for the febrile neutropenic patient.
European journal of cancer care 2011;20(5):679-85.
2011: L D de Hosson; H P H Kremer; Dirk J Lefeber; Dietger Niederwieser; Frank W M B Preijers; NP Schaap; H Al-Ali; Wil Allebes; N M A Blijlevens; B P C van de Warrenburg; Bert A van der Reijden; A V M B Schattenberg
Adult metachromatic leukodystrophy treated by allo-SCT and a review of the literature.
Bone marrow transplantation 2011;46(8):1071-6.
2011: W J F M Van der Velden; J Peter Donnelly; Ton Feuth; W B C Stevens; N M A Blijlevens
Issues in genetic association studies: limitations of statistical analysis and biological plausibility.
Bone marrow transplantation 2011;46(6):906-7.
2011: Louis Y A Chai; Mark G J de Boer; Walter J F M van der Velden; Theo S Plantinga; Annemiek B van Spriel; Cor Jacobs; Constantijn J M Halkes; Alieke G Vonk; N M A Blijlevens; Jaap T van Dissel; Peter J Donnelly; Bart Jan Kullberg; Johan Maertens; Mihai G Netea
The Y238X stop codon polymorphism in the human β-glucan receptor dectin-1 and susceptibility to invasive aspergillosis.
The Journal of infectious diseases 2011;203(5):736-43.
2010: Walter J F M van der Velden; Theo S Plantinga; Ton Feuth; J Peter Donnelly; Mihai G Netea; N M A Blijlevens
The incidence of acute graft-versus-host disease increases with Candida colonization depending the dectin-1 gene status.
Clinical immunology (Orlando, Fla.) 2010;136(2):302-6.
2010: Walter J F M van der Velden; Alexandra H E Herbers; Ton Feuth; NP Schaap; J Peter Donnelly; N M A Blijlevens
Intestinal damage determines the inflammatory response and early complications in patients receiving conditioning for a stem cell transplantation.
PloS one 2010;5(12):e15156.
2010: Roger J M Brüggemann; N M A Blijlevens; David M Burger; Barbara Franke; Peter F Troke; J Peter Donnelly
Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients.
The Journal of antimicrobial chemotherapy 2010;65(1):107-13.
2010: Maarten van Vliet; J Peter Donnelly; Carin M J Potting; N M A Blijlevens
Continuous non-invasive monitoring of the skin temperature of HSCT recipients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2010;18(1):37-42.
2009: Theo S Plantinga; Walter J F M van der Velden; Bart Ferwerda; Annemiek B van Spriel; Gosse Adema; Ton Feuth; J Peter Donnelly; Gordon D Brown; Bart Jan Kullberg; N M A Blijlevens; Mihai G Netea
Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(5):724-32.
2009: A H E Herbers; B Verbruggen; Frank van de Veerdonk; M Van Kraaij; N M A Blijlevens; I R O Novakova
Misleading one-stage coagulation factor assay during rFVIIa treatment in lupus patient.
Haemophilia : the official journal of the World Federation of Hemophilia 2009;15(5):1164-6.
2009: N M A Blijlevens
Neutropenic enterocolitis: challenges in diagnosis and treatment.
Clinical advances in hematology & oncology : H&O 2009;7(8):528-30.
2009: W J F M van der Velden; N M A Blijlevens; Frans Maas; NP Schaap; Joop H Jansen; Bert A van der Reijden; Ton Feuth; Harry Dolstra; J Peter Donnelly
NOD2 polymorphisms predict severe acute graft-versus-host and treatment-related mortality in T-cell-depleted haematopoietic stem cell transplantation.
Bone marrow transplantation 2009;44(4):243-8.
2009: Roger J M Brüggemann; Jan-Willem C Alffenaar; N M A Blijlevens; Eliane M Billaud; Jos G W Kosterink; Paul E Verweij; David Burger
Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(10):1441-58.
2009: N M A Blijlevens; Richard Logan; Mihai G Netea
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Mucositis: from febrile neutropenia to febrile mucositis.
The Journal of antimicrobial chemotherapy 2009;63 Suppl 1():i36-40.
2009: FM Verduyn Lunel; J Peter Donnelly; H A L van der Lee; N M A Blijlevens; Paul E Verweij
Circulating Candida-specific anti-mannan antibodies precede invasive candidiasis in patients undergoing myelo-ablative chemotherapy.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2009;15(4):380-6.
2009: Joep P M Derikx; N M A Blijlevens; J Peter Donnelly; H Fujii; T Kanda; Annemarie A van Bijnen; Erik Heineman; Wim A Buurman
Loss of enterocyte mass is accompanied by diminished turnover of enterocytes after myeloablative therapy in haematopoietic stem-cell transplant recipients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(2):337-42.
2009: Walter J F M van der Velden; Thijs M P van Iersel; N M A Blijlevens; J Peter Donnelly
Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11).
BMC medicine 2009;7():44.
2009: W J F M van der Velden; N M A Blijlevens; Ton Feuth; J Peter Donnelly
Febrile mucositis in haematopoietic SCT recipients.
Bone marrow transplantation 2009;43(1):55-60.
2009: W J F M van der Velden; A H E Herbers; N M A Blijlevens
Palifermin in allogeneic HSCT: many questions remain.
Bone marrow transplantation 2009;43(1):85-6.
2008: L A G Sibelt; N Aboosy; W J F M van der Velden; N M A Blijlevens; W A M Blokx; M M B Seyger
Palifermin-induced flexural hyperpigmentation: a clinical and histological study of five cases.
The British journal of dermatology 2008;159(5):1200-3.
2008: A H E Herbers; N M A Blijlevens; J Peter Donnelly; T J M de Witte
Bacteraemia coincides with low citrulline concentrations after high-dose melphalan in autologous HSCT recipients.
Bone marrow transplantation 2008;42(5):345-9.
2008: Carin M J Potting; Arno Mank; N M A Blijlevens; J Peter Donnelly; Theo van Achterberg
Providing oral care in haematological oncology patients: nurses' knowledge and skills.
European journal of oncology nursing : the official journal of European Oncology Nursing Society 2008;12(4):291-8.
2008: Paul E Verweij; János Varga; Jos Houbraken; Antonius J M M Rijs; Frans M Verduynlunel; N M A Blijlevens; Yvonne R Shea; Steven M Holland; Adilia Warris; Willem J G Melchers; Robert A Samson
Emericella quadrilineata as cause of invasive aspergillosis.
Emerging infectious diseases 2008;14(4):566-72.
2008: Monique Mennink; Dorien Ruegebrink; Rocus R Klont; Adilia Warris; N M A Blijlevens; J Peter Donnelly; Paul E Verweij
Improved detection of circulating Aspergillus antigen by use of a modified pretreatment procedure.
Journal of clinical microbiology 2008;46(4):1391-7.
2008: W J F M van der Velden; N M A Blijlevens; J Peter Donnelly
The potential role of lactoferrin and derivatives in the management of infectious and inflammatory complications of hematology patients receiving a hematopoietic stem cell transplantation.
Transplant infectious disease : an official journal of the Transplantation Society 2008;10(2):80-9.
2007: Paul E Verweij; W J F M van der Velden; J Peter Donnelly; N M A Blijlevens; Adilia Warris
[Invasive zygomycosis in patients treated for haematological malignancies].
Nederlands tijdschrift voor geneeskunde 2007;151(47):2597-602.
2007: N M A Blijlevens; J Peter Donnelly; D Yakar; CE van Die; T de Witte
Determining mucosal barrier injury to the oesophagus using CT scan.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2007;15(9):1105-8.
2007: N M A Blijlevens; S Sonis
Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(5):817-26.
2007: N M A Blijlevens
Cytotoxic treatment-induced gastrointestinal symptoms.
Current opinion in supportive and palliative care 2007;1(1):16-22.
2006: M P Hendriks; N M A Blijlevens; A V M B Schattenberg; David Burger; J Peter Donnelly
Cyclosporine short infusion and C2 monitoring in haematopoietic stem cell transplant recipients.
Bone marrow transplantation 2006;38(7):521-5.
2006: W J F M van der Velden; N M A Blijlevens; Rocus R Klont; J Peter Donnelly; Paul E Verweij
Primary hepatic invasive aspergillosis with progression after rituximab therapy for a post transplantation lymphoproliferative disorder.
Annals of hematology 2006;85(9):621-3.
2006: Rocus R Klont; Monique Mennink; Dorien Ruegebrink; Antonius J M M Rijs; N M A Blijlevens; J Peter Donnelly; Paul E Verweij
Paradoxical increase in circulating Aspergillus antigen during treatment with caspofungin in a patient with pulmonary aspergillosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(3):e23-5.
2006: B A J Veldman; Paul E Verweij; N M A Blijlevens
Successful treatment of liposomal amphotericin B refractory Candida glabrata fungaemia in a patient undergoing a stem cell transplantation.
The Netherlands journal of medicine 2006;64(4):127-9.
2005: N M A Blijlevens; J Peter Donnelly; Ben E de Pauw
Microbiologic consequences of new approaches to managing hematologic malignancies.
Reviews in clinical and experimental hematology 2005;9(2):E2.
2005: N M A Blijlevens
Implications of treatment-induced mucosal barrier injury.
Current opinion in oncology 2005;17(6):605-10.
2005: N M A Blijlevens; J Peter Donnelly; A H J Naber; A V M B Schattenberg; B E DePauw
A randomised, double-blinded, placebo-controlled, pilot study of parenteral glutamine for allogeneic stem cell transplant patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2005;13(10):790-6.
2005: N M A Blijlevens; J Peter Donnelly; B E DePauw
Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic stem cell transplant recipients.
Bone marrow transplantation 2005;36(8):703-7.
2005: N M A Blijlevens; J Peter Donnelly; Ben E de Pauw
Prospective evaluation of gut mucosal barrier injury following various myeloablative regimens for haematopoietic stem cell transplant.
Bone marrow transplantation 2005;35(7):707-11.
2005: Paul E Verweij; J Peter Donnelly; CE van Die; N M A Blijlevens; Bart Jan Kullberg; Ben E de Pauw
[Improved diagnostics in invasive aspergillosis and systematic monitoring in patients at high risk of infection].
Nederlands tijdschrift voor geneeskunde 2005;149(11):561-7.
2005: Ludy C H W Lutgens; N M A Blijlevens; Nicolaas E P Deutz; J Peter Donnelly; Philippe Lambin; Ben E de Pauw
Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests.
Cancer 2005;103(1):191-9.
2004: N M A Blijlevens; Ludy C H W Lutgens; A V M B Schattenberg; J Peter Donnelly
Citrulline: a potentially simple quantitative marker of intestinal epithelial damage following myeloablative therapy.
Bone marrow transplantation 2004;34(3):193-6.
2004: N M A Blijlevens; Belinda van't Land; J Peter Donnelly; Laura M'Rabet; Ben E de Pauw
Measuring mucosal damage induced by cytotoxic therapy.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2004;12(4):227-33.
2004: Belinda van't Land; N M A Blijlevens; J Marteijn; S Timal; J Peter Donnelly; T J M de Witte; Laura M'Rabet
Role of curcumin and the inhibition of NF-kappaB in the onset of chemotherapy-induced mucosal barrier injury.
Leukemia 2004;18(2):276-84.
2003: J Peter Donnelly; N M A Blijlevens; A V M B Schattenberg
Monitoring cyclosporine using blood drawn via a central venous catheter.
Bone marrow transplantation 2003;32(10):1037.
2003: J Peter Donnelly; N M A Blijlevens; C A H Verhagen
Can anything be done about oral mucositis?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(4):505-7.
2003: Susan N O'Brien; N M A Blijlevens; tahsine Mahfouz; Elias J Anaissie
Infections in patients with hematological cancer: recent developments.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2003;():438-72.
2002: N M A Blijlevens; J Peter Donnelly; Jacques Meis; Paul E Verweij; Ben E de Pauw
Aspergillus galactomannan antigen levels in allogeneic haematopoietic stem cell transplant recipients given total parenteral nutrition.
Transplant infectious disease : an official journal of the Transplantation Society 2002;4(2):64-5.
2002: N M A Blijlevens; J Peter Donnelly; Ben E de Pauw
Impaired gut function as risk factor for invasive candidiasis in neutropenic patients.
British journal of haematology 2002;117(2):259-64.
2001: N M A Blijlevens; J Peter Donnelly; Ben E de Pauw
Empirical therapy of febrile neutropenic patients with mucositis: challenge of risk-based therapy.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2001;7 Suppl 4():47-52.
2000: N M A Blijlevens; J Peter Donnelly; Jacques Meis; M H De Keizer; Ben E de Pauw
Procalcitonin does not discriminate infection from inflammation after allogeneic bone marrow transplantation.
Clinical and diagnostic laboratory immunology 2000;7(6):889-92.
2000: N M A Blijlevens; J Peter Donnelly; Ben E de Pauw
Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview.
Bone marrow transplantation 2000;25(12):1269-78.